Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 570894, 11 pages
http://dx.doi.org/10.1155/2014/570894
Research Article

Reduction of IL-17A Might Suppress the Th1 Response and Promote the Th2 Response by Boosting the Function of Treg Cells during Silica-Induced Inflammatory Response In Vitro

Division of Pneumoconiosis, School of Public Health, China Medical University, No. 92 North 2nd Road, Heping District, Shenyang, Liaoning 110001, China

Received 6 November 2013; Revised 30 December 2013; Accepted 3 January 2014; Published 16 February 2014

Academic Editor: Nina Ivanovska

Copyright © 2014 Wen Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Rimal, A. K. Greenberg, and N. W. Rom, “Basic pathogenetic mechanisms in silicosis: current understanding,” Current Opinion in Pulmonary Medicine, vol. 11, no. 2, pp. 169–173, 2005. View at Google Scholar · View at Scopus
  2. S. L. Cassel, S. C. Eisenbarth, S. S. Iyer et al., “The Nalp3 inflammasome is essential for the development of silicosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 26, pp. 9035–9040, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Zhang, T. C. Lee, B. Guillemin, M.-C. Yu, and W. N. Rom, “Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure,” Journal of Immunology, vol. 150, no. 9, pp. 4188–4196, 1993. View at Google Scholar · View at Scopus
  4. C. T. Migliaccio, R. F. Hamilton Jr., and A. Holian, “Increase in a distinct pulmonary macrophage subset possessing an antigen-presenting cell phenotype and in vitro APC activity following silica exposure,” Toxicology and Applied Pharmacology, vol. 205, no. 2, pp. 168–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Hamilton R.F., J. C. Pfau, G. D. Marshall, and A. Holian, “Silica and PM1648 modify human alveolar macrophage antigen-presenting cell activity in vitro,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 20, supplement 1, pp. 75–84, 2001. View at Google Scholar · View at Scopus
  6. H. François, “New developments in the understanding of immunology in silicosis,” Current Opinion in Allergy and Clinical Immunology, vol. 7, no. 2, pp. 168–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Zhu and W. E. Paul, “CD4 T cells: fates, functions, and faults,” Blood, vol. 112, no. 5, pp. 1557–1569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. G. S. Davis, C. E. Holmes, L. M. Pfieiffer, and D. R. Hemenway, “Lymphocytes, lymphokines, silicosis,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 20, supplement 1, pp. 53–65, 2001. View at Google Scholar · View at Scopus
  9. H. Garn, A. Friedetzky, A. Kirchner, R. Jäger, and D. Gemsa, “Experimental silicosis: a shift to a preferential IFN-γ-based Th1 response in thoracic lymph nodes,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 278, no. 6, pp. L1221–L1230, 2000. View at Google Scholar · View at Scopus
  10. C. T. Migliaccio, M. C. Buford, F. Jessop, and A. Holian, “The IL-4Rα pathway in macrophages and its potential role in silica-induced pulmonary fibrosis,” Journal of Leukocyte Biology, vol. 83, no. 3, pp. 630–639, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Barbarin, Z. Xing, M. Delos, D. Lison, and F. Huaux, “Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles,” American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 288, no. 5, pp. L841–L848, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Kidd, “Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease,” Alternative Medicine Review, vol. 8, no. 3, pp. 223–246, 2003. View at Google Scholar · View at Scopus
  13. F. Liu, J. Liu, D. Weng et al., “CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice,” PLoS ONE, vol. 5, no. 11, Article ID e15404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, “Regulatory T cells and immune tolerance,” Cell, vol. 133, no. 5, pp. 775–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Lo Re, L. Dumoutier, I. Couillin et al., “IL-17A-producing γδ T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis,” Journal of Immunology, vol. 184, no. 11, pp. 6367–6377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, “TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells,” Immunity, vol. 24, no. 2, pp. 179–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Sutton, C. Brereton, B. Keogh, K. H. G. Mills, and E. C. Lavelle, “A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis,” The Journal of Experimental Medicine, vol. 203, no. 7, pp. 1685–1691, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. W.-W. Lee, S. W. Kang, J. Choi et al., “Regulating human Th17 cells via differential expression of IL-1 receptor,” Blood, vol. 115, no. 3, pp. 530–540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Gasse, N. Riteau, R. Vacher et al., “IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis,” PLoS ONE, vol. 6, no. 8, Article ID e23185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Pazyar, A. Feily, and R. Yaghoobi, “An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases,” Current Clinical Pharmacology, vol. 7, pp. 271–275, 2012. View at Google Scholar
  22. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Z. Yao, W. C. Fanslow, M. F. Seldin et al., “Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor,” Immunity, vol. 3, no. 6, pp. 811–821, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. E. V. Dang, J. Barbi, H.-Y. Yang et al., “Control of TH17/Treg balance by hypoxia-inducible factor 1,” Cell, vol. 146, no. 5, pp. 772–784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Uyttenhove and J. van Snick, “Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis,” European Journal of Immunology, vol. 36, no. 11, pp. 2868–2874, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. D. T. Nardelli, M. A. Burchill, D. M. England, J. Torrealba, S. M. Callister, and R. F. Schell, “Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 6, pp. 1075–1084, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. F. L. van de Veerdonk, M. G. Netea, C. A. Dinarello, and L. A. B. Joosten, “Inflammasome activation and IL-1β and IL-18 processing during infection,” Trends in Immunology, vol. 32, no. 3, pp. 110–116, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nambu, S. Nakae, and Y. Iwakura, “IL-1β, but not IL-1α, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses,” International Immunology, vol. 18, no. 5, pp. 701–712, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. W. P. Arend, G. Palmer, and C. Gabay, “IL-1, IL-18, and IL-33 families of cytokines,” Immunological Reviews, vol. 223, no. 1, pp. 20–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. C. M. Sayes, K. L. Reed, and D. B. Warheit, “Assessing toxicology of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles,” Toxicological Sciences, vol. 97, no. 1, pp. 163–180, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. D. B. Warheit, T. R. Webb, V. L. Colvin, K. L. Reed, and C. M. Sayes, “Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics,” Toxicological Sciences, vol. 95, no. 1, pp. 270–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. R. Mangan, L. E. Harrington, D. B. O. ’Quinn et al., “Transforming growth factor-beta induces development of the T(H)17 lineage,” Nature, vol. 441, pp. 231–234, 2006. View at Google Scholar
  33. J.-M. Doisne, V. Soulard, C. Bécourt et al., “Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria,” Journal of Immunology, vol. 186, no. 2, pp. 662–666, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. R. F. Hamilton Jr., S. A. Thakur, and A. Holian, “Silica binding and toxicity in alveolar macrophages,” Free Radical Biology and Medicine, vol. 44, no. 7, pp. 1246–1258, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Zhou, I. I. Ivanov, R. Spolski et al., “IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways,” Nature Immunology, vol. 8, no. 9, pp. 967–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. P. Rubtsov, J. P. Rasmussen, E. Y. Chi et al., “Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces,” Immunity, vol. 28, no. 4, pp. 546–558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. O. Li, Y. Y. Wan, and R. A. Flavell, “T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation,” Immunity, vol. 26, no. 5, pp. 579–591, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. A.-G. Besnard, D. Togbe, I. Couillin et al., “InflammasomeIL-1Th17 response in allergic lung inflammation,” Journal of Molecular Cell Biology, vol. 4, no. 1, pp. 3–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Chung, S. H. Chang, G. J. Martinez et al., “Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling,” Immunity, vol. 30, no. 4, pp. 576–587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Usui, J. C. Preiss, Y. Kanno et al., “T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription,” The Journal of Experimental Medicine, vol. 203, no. 3, pp. 755–766, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. F. W. Fitch, M. D. McKisic, D. W. Lancki, and T. F. Gajewski, “Differential regulation of murine T lymphocyte subsets,” Annual Review of Immunology, vol. 11, pp. 29–48, 1993. View at Google Scholar · View at Scopus
  42. K. Ghoreschi, A. Laurence, X.-P. Yang et al., “Generation of pathogenic TH 17 cells in the absence of TGF-β 2 signalling,” Nature, vol. 467, no. 7318, pp. 967–971, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. Y.-H. Wang, K. S. Voo, B. Liu et al., “A novel subset of CD4+ TH2 memory/ effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma,” The Journal of Experimental Medicine, vol. 207, no. 11, pp. 2479–2491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Manel, D. Unutmaz, and D. R. Littman, “The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt,” Nature Immunology, vol. 9, no. 6, pp. 641–649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. J. I. Herseth, M. Refsnes, M. Låg, and P. E. Schwarze, “Role of IL-1β and COX2 in silica-induced IL-6 release and loss of pneumocytes in co-cultures,” Toxicology in Vitro, vol. 23, no. 7, pp. 1342–1353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Volpe, N. Servant, R. Zollinger et al., “A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses,” Nature Immunology, vol. 9, no. 6, pp. 650–657, 2008. View at Publisher · View at Google Scholar · View at Scopus